Risk Minimisation Materials

Thalidomide Adverse Event Form

The safe use of thalidomide is of paramount importance. Adverse events (and cases of suspected or confirmed pregnancy or foetal exposure) should be reported to Celgene. Any adverse event should also be reported to the MHRA via the Yellow Card scheme website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

For Healthcare Professionals